相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial
Liselotte M. S. Boeve et al.
EUROPEAN UROLOGY (2019)
Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease?
Fabian Lohaus et al.
EUROPEAN UROLOGY (2019)
Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis
Nicola Fossati et al.
EUROPEAN UROLOGY (2019)
The Impact of 68Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study
Paul J. Roach et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Treatment of Advanced Prostate Cancer-A Review of Current Therapies and Future Promise
Semini Sumanasuriya et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Early Androgen Deprivation Therapy Improves Survival, But How Do We Determine in Whom?
Mark Frydenberg et al.
EUROPEAN UROLOGY (2018)
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
Shankar Siva et al.
EUROPEAN UROLOGY (2018)
Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers
Gladell P. Paner et al.
EUROPEAN UROLOGY (2018)
Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer Reply
Piet Ost et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Christos E. Kyriakopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
Piet Ost et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Use of stereotactic body radiation therapy for oligometastatic recurrent prostate cancer: A systematic review
Ricardo Alencar Vilela et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2018)
Survival benefit of local versus no local treatment for metastatic prostate cancerImpact of baseline PSA and metastatic substages
Raisa S. Pompe et al.
PROSTATE (2018)
Interim results of a randomized trial of observation versus SABR for oligometastatic prostate cancer
P. Tran et al.
RADIOTHERAPY AND ONCOLOGY (2018)
68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review
Julia Corfield et al.
WORLD JOURNAL OF UROLOGY (2018)
Stereotactic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of a Randomized Trial
D. A. Palma et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Christopher C. Parker et al.
LANCET (2018)
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group
Frederic E. Lecouvet et al.
LANCET ONCOLOGY (2018)
Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography
Andrew Kneebone et al.
EUROPEAN UROLOGY ONCOLOGY (2018)
Does robot-assisted radical prostatectomy benefit patients with prostate cancer and bone oligometastases?
Won Sik Jang et al.
BJU INTERNATIONAL (2018)
Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations
Jeffrey J. Tosoian et al.
NATURE REVIEWS UROLOGY (2017)
The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer
D. Porres et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2017)
Robot-assisted Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer
Francesco Montorsi et al.
EUROPEAN UROLOGY (2017)
The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis
Bjorn Loppenberg et al.
EUROPEAN UROLOGY (2017)
Local Therapy Improves Survival in Metastatic Prostate Cancer
Sami-Ramzi Leyh-Bannurah et al.
EUROPEAN UROLOGY (2017)
68Ga-PSMA-11PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study
Wolfgang Peter Fendler et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Karim Fizazi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
N. D. James et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning
Drew Moghanaki et al.
SEMINARS IN RADIATION ONCOLOGY (2017)
Testing radical prostatectomy in men with prostate cancer and oligometastases to the bone: a randomized controlled feasibility trial
Prasanna Sooriakumaran
BJU INTERNATIONAL (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy
Aurelie De Bruycker et al.
BJU INTERNATIONAL (2017)
Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy
Elisabetta Ponti et al.
EUROPEAN UROLOGY FOCUS (2017)
PET/CT with C-11-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data
Stefano Fanti et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons
Laura Evangelista et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis
Marlon Perera et al.
EUROPEAN UROLOGY (2016)
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Nicholas D. James et al.
LANCET (2016)
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial
Gillian M. Duchesne et al.
LANCET ONCOLOGY (2016)
Cancer-specific and overall survival in patients with recurrent prostate cancer who underwent salvage extended pelvic lymph node dissection
Daniar K. Osmonov et al.
BMC UROLOGY (2016)
Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer Data From Patients in the Control Arm of the STAMPEDE Trial
Nicholas D. James et al.
JAMA ONCOLOGY (2016)
Mid-term Outcomes Following Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Status Post-radical Prostatectomy
Fabio Zattoni et al.
EUROPEAN UROLOGY FOCUS (2016)
Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature
Piet Ost et al.
EUROPEAN UROLOGY (2015)
Identifying Optimal Candidates for Local Treatment of the Primary Tumor Among Patients Diagnosed with Metastatic Prostate Cancer: A SEER-based Study
Nicola Fossati et al.
EUROPEAN UROLOGY (2015)
Long-term Outcomes of Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer: Results of a Single-institution Series with a Minimum Follow-up of 5 Years
Nazareno Suardi et al.
EUROPEAN UROLOGY (2015)
Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer after Radical Prostatectomy
Derya Tilki et al.
JOURNAL OF UROLOGY (2015)
Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis
Raj Satkunasivam et al.
JOURNAL OF UROLOGY (2015)
Diagnostic Performance of Diffusion-weighted Magnetic Resonance Imaging in Bone Malignancy Evidence From a Meta-Analysis
Li-Peng Liu et al.
MEDICINE (2015)
The evolutionary history of lethal metastatic prostate cancer
Gunes Gundem et al.
NATURE (2015)
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Christopher J. Sweeney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
Matthew K. H. Hong et al.
NATURE COMMUNICATIONS (2015)
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study
Stephen H. Culp et al.
EUROPEAN UROLOGY (2014)
The Impact of Definitive Local Therapy for Lymph Node-Positive Prostate Cancer: A Population-Based Study
Chad G. Rusthoven et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Prognostic Factors Influencing Prostate Cancer-Specific Survival in Non-Castrate Patients with Metastatic Prostate Cancer
Piet Ost et al.
PROSTATE (2014)
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis
Guohua Shen et al.
SKELETAL RADIOLOGY (2014)
Comparison of FDG whole-body PET/CT and gadolinium-enhanced whole-body MRI for distant malignancies in patients with malignant tumors: a meta-analysis
G. Z. Xu et al.
ANNALS OF ONCOLOGY (2013)
Tracking the clonal origin of lethal prostate cancer
Michael C. Haffner et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Salvage Lymph Node Dissection with Adjuvant Radiotherapy for Nodal Recurrence of Prostate Cancer
C. A. Jilg et al.
JOURNAL OF UROLOGY (2012)
Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
S. Schwarzenboeck et al.
THERANOSTICS (2012)
Novel Insights of Oligometastases and Oligo-Recurrence and Review of the Literature
Yuzuru Niibe et al.
PULMONARY MEDICINE (2012)
Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy
Hui-Lin Yang et al.
EUROPEAN RADIOLOGY (2011)
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography
Patrizio Rigatti et al.
EUROPEAN UROLOGY (2011)
The Use of F-18 Choline PET in the Assessment of Bone Metastases in Prostate Cancer: Correlation with Morphological Changes on CT
Mohsen Beheshti et al.
MOLECULAR IMAGING AND BIOLOGY (2010)
Tumor Self-Seeding by Circulating Cancer Cells
Mi-Young Kim et al.
CELL (2009)
The metastatic niche: adapting the foreign soil
Bethan Psaila et al.
NATURE REVIEWS CANCER (2009)
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer:: a meta-analysis
A. M. Hovels et al.
CLINICAL RADIOLOGY (2008)
Use of surgery among elderly patients with stage IV colorectal cancer
LKF Temple et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer
RC Flanigan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
